Related Experiment Videos

Response of alveolar macrophages to amiodarone and desethylamiodarone, in vitro

C L Ogle1, M J Reasor

  • 1Department of Pharmacology and Toxicology, West Virginia University Health Sciences Center, Morgantown 26506.

Toxicology
|May 31, 1990
PubMed

Insights

Amiodarone lung toxicity may stem from its metabolite, desethylamiodarone. This study shows desethylamiodarone causes phospholipidosis and more cytotoxicity in rat alveolar macrophages than amiodarone alone or combined.

Area of Science:

  • Pharmacology
  • Toxicology
  • Cell Biology

Background:

  • Amiodarone, an antiarrhythmic drug, can cause lung damage.
  • Amiodarone is metabolized into desethylamiodarone and other compounds.
  • Both amiodarone and its metabolites accumulate in the lungs, complicating toxicity studies.

Purpose of the Study:

  • To investigate the individual and combined effects of amiodarone and desethylamiodarone on rat alveolar macrophages.
  • To determine the role of desethylamiodarone in amiodarone-induced pulmonary toxicity.

Main Methods:

  • Primary cultures of rat alveolar macrophages were used.
  • Cells were exposed to amiodarone and desethylamiodarone individually and in combination.
  • Cytotoxicity was assessed by lactate dehydrogenase release.
  • Cellular phospholipidosis was evaluated by the formation of lamellar inclusions.

Main Results:

  • Neither amiodarone nor desethylamiodarone were metabolized by the macrophages.
  • Both drugs induced lamellar inclusions, indicating phospholipidosis.
  • Desethylamiodarone induced phospholipidosis faster than amiodarone.
  • Desethylamiodarone was more cytotoxic than amiodarone at lower concentrations and shorter exposure times.
  • Combined exposure resulted in more than additive cytotoxicity.

Conclusions:

  • In vitro alveolar macrophage cultures are useful for studying amiodarone pulmonary toxicity.
  • Desethylamiodarone contributes significantly to amiodarone-induced lung toxicity.

Related Concept Videos